Unknown

Dataset Information

0

An observed association between angiotensin-converting enzyme 2 polymorphisms and COVID-19 severity in China.

ABSTRACT:

SUBMITTER: Wang J 

PROVIDER: S-EPMC8556693 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study.
| S-EPMC8010897 | biostudies-literature
Unknown Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.
| S-EPMC7305566 | biostudies-literature
Unknown The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension.
| S-EPMC7971559 | biostudies-literature
Unknown Angiotensin converting enzyme-2 as therapeutic target in COVID-19.
| S-EPMC7214324 | biostudies-literature
Unknown Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases.
| S-EPMC7796300 | biostudies-literature
Unknown The effect of angiotensin-converting enzyme levels on COVID-19 susceptibility and severity: a Mendelian randomization study.
| S-EPMC7799043 | biostudies-literature
Unknown The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 Infection.
| S-EPMC8004186 | biostudies-literature
Unknown Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies.
| S-EPMC7938645 | biostudies-literature
Unknown COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice.
| S-EPMC7269898 | biostudies-literature
Unknown Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers.
| S-EPMC7478439 | biostudies-literature